Yeast infections are infections caused by the overgrowth of yeasts, single-celled fungi, most commonly species of the genus Candida that normally live harmlessly on the skin and mucous membranes. When the natural balance of microorganisms is disturbed, for example by antibiotic use, weakened immunity, hormonal chang…
Yeast infections are infections caused by the overgrowth of yeasts, single-celled fungi, most commonly species of the genus Candida that normally live harmlessly on the skin and mucous membranes. When the natural balance of microorganisms is disturbed, for example by antibiotic use, weakened immunity, hormonal changes, or underlying illness, these yeasts can multiply and cause infection of the mouth, throat, genital tract, skin, or, in serious cases, the bloodstream and internal organs. Advanced treatment for yeast infection refers to the range of antifungal therapies and management strategies used when infections are severe, recurrent, resistant to first-line agents, or occur in people with compromised immune systems. These approaches include systemic antifungal drugs from classes such as the azoles, polyenes, and echinocandins, susceptibility testing to guide drug choice, and management of the underlying conditions that allow yeast to flourish. Accurate identification of the fungal species is important because different yeasts vary in their response to treatment. Fungal Diversity publishes peer-reviewed research across mycology and medical fungal disease, including reports of invasive yeast infections such as Saccharomyces fungemia in immunocompromised patients. This page gathers open-access research relevant to yeast infections and their diagnosis and treatment.
1 peer-reviewed article, ranked by relevance. Each links to its DOI.